PT Bundamedik Tbk

Jakarta Stock Exchange BMHS.JK

PT Bundamedik Tbk Operating Cash Flow for the year ending December 31, 2023: USD 3.34 M

PT Bundamedik Tbk Operating Cash Flow is USD 3.34 M for the year ending December 31, 2023, a -78.00% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

PT Bundamedik Tbk Operating Cash Flow for the year ending December 31, 2022 was USD 15.20 M, a -37.87% change year over year.
PT Bundamedik Tbk Operating Cash Flow for the year ending December 31, 2021 was USD 24.46 M, a 83.57% change year over year.
PT Bundamedik Tbk Operating Cash Flow for the year ending December 31, 2020 was USD 13.33 M, a 106.29% change year over year.
PT Bundamedik Tbk Operating Cash Flow for the year ending December 31, 2019 was USD 6.46 M, a 113.78% change year over year.

Key data

Date	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid

Jakarta Stock Exchange: BMHS.JK

PT Bundamedik Tbk

CEO	Mr. Agus Heru Darjono
IPO Date	July 6, 2021
Location	Indonesia
Headquarters	Jl. Teuku Cik Ditiro No.28
Employees	1,434
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cosmetics Dental Care Drugstores & Retail Pharmacies Hospitals & Clinics Medical Instruments Personal Care

Description

PT Bundamedik Tbk provides health care services in Indonesia. As of December 31, 2021, the company operated 2 maternal and child hospitals, 3 general hospitals, 2 clinics, 10 IVF clinics, and 14 diagnostic laboratories. It also engages in the distribution of drugs, pharmaceuticals, and medical devices; and hotel, medical tourism, and management consulting businesses. The company was founded in 1973 and is headquartered in Jakarta Pusat, Indonesia. PT Bunda Medik is a subsidiary of PT Bunda Investama Indonesia.

Key trends

Past 5 years